Riskpilot← Back to searchSign inGet full accessCuractus AB
ABActiveOrg 5590883624Marknadsvägen 111General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2024
SEK 256K
-31% vs 2023
EBITDA margin
75.9%
-26% vs 2023
Equity ratio
57.1%
Financial strength
Net profit 2024
SEK 134K
-58% vs 2023
| Revenue | SEK 256K | -31% |
| EBITDA | SEK 194K | -26% |
| Net profit | SEK 134K | -58% |
| Total assets | SEK 639K | -4% |
| Equity | SEK 365K | -15% |
| Employees | 1 | — |
Legal name
Curactus AB
Org number
5590883624
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 december 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Hälso och sjukvård, både inom sluten och öppenvård. Verksamheten skall innehålla både kliniskt arbete och konsultativ verksamhet. Förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Marknadsvägen 111
Email
curactus@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 439 | 85 | 171 | 370 | 256 |
| Staff expenses | — | — | −13 | −46 | −21 |
| EBITDA | 341 | −1 | 113 | 264 | 194 |
| Depreciation & amort. | −6 | −6 | −6 | −6 | −3 |
| EBIT | 335 | −7 | 107 | 257 | 191 |
| Net financials | −1 | −1 | −0 | 167 | 22 |
| Profit before tax | 251 | 179 | 107 | 359 | 164 |
| Tax | −54 | −39 | −23 | −40 | −30 |
| Net profit | 197 | 140 | 84 | 319 | 134 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 823 | 467 | 450 | 666 | 639 |
| Equity | 362 | 352 | 312 | 431 | 365 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 189 | 31 | 54 | 87 | 76 |
| Total debt | 189 | 31 | 54 | 87 | 76 |
EBITDA margin
75.9%
This company
15.8%
Market median
+380% vs market
20202024
Equity ratio
57.1%
This company
38.2%
Market median
+49% vs market
20202024
Return on equity
36.8%
This company
18.4%
Market median
+100% vs market
20202024
Net profit margin
52.4%
This company
8.1%
Market median
+547% vs market
20202024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20202024
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curactus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Mårten Kinn | Board of Directors | 0 companies |
| Anna Maria Kinn Gerstner | Deputy Board Member | 0 companies |